Human Phenotype Ontology 
Grandparent Node:
expand
Abnormal inflammatory response (HP:0012647)help
Parent Node:
expand
Abnormal liver morphology (HP:0410042)help
Parent Node:
expand
Increased inflammatory response (HP:0012649)help
..Starting node
..expand
Hepatitis (HP:0012115)help
Term ID: 12115
Name: Hepatitis
Synonym: Liver inflammation
Definition: Inflammation of the liver.
Comments:
Reference: HP:0012115
Genes and Diseases:
 
       Child Nodes:
........expandFulminant hepatitis (HP:0004787) help
........expandViral hepatitis (HP:0006562) help
................... HP:0001412 Enteroviral hepatitis
................... HP:0006572 Subacute progressive viral hepatitis
........expandGiant cell hepatitis (HP:0200084) help
........expandAcute hepatitis (HP:0200119) help
........expandAtypical or prolonged hepatitis (HP:0200122) help
........expandChronic hepatitis (HP:0200123) help
................... HP:0200120 Chronic active hepatitis
................... HP:0200124 Chronic hepatitis due to cryptosporidium infection

 Sister Nodes: 
..expandCholangitis (HP:0030151) help
..expandChondritis (HP:0100662) help
..expandEndocarditis (HP:0100584) help
..expandEpididymitis (HP:0000031) help
..expandFasciitis (HP:0100537) help
..expandGastrointestinal inflammation (HP:0004386) help
..expandInflammatory abnormality of the eye (HP:0100533) help
..expandInflammatory abnormality of the skin (HP:0011123) help
..expandLymphadenitis (HP:0002840) help
..expandMeningitis (HP:0001287) help
..expandMyelitis (HP:0012486) help
..expandMyositis (HP:0100614) help
..expandNephritis (HP:0000123) help
..expandOptic neuritis (HP:0100653) help
..expandOsteomyelitis (HP:0002754) help
..expandOtitis media (HP:0000388) help
..expandPancreatitis (HP:0001733) help
..expandPanniculitis (HP:0012490) help
..expandPeriodontitis (HP:0000704) help
..expandPneumonia (HP:0002090) help
..expandProstatitis (HP:0000024) help
..expandSerositis (HP:0045073) help
..expandSinusitis (HP:0000246) help
..expandStomatitis (HP:0010280) help
..expandThyroiditis (HP:0100646) help
..expandUrinary bladder inflammation (HP:0100577) help
..expandVaginitis (HP:0030683) help
InputHPO IDHPO termDistanceGeneGene id entrezDiseaseIdDiseaseNameDiseaseMIMConceptIDSourceTypical associationHGMD variantsClinVar variantsHGNC IDGeneMIM
 
HPO disease - gene - phenotype typical associations:
HP:0012115HP:0012115Hepatitis0ATP7A CL E G H538198ORPHA11751869300011
HP:0012115HP:0012115Hepatitis0C1S CL E G H716613783Complement component c1s deficiency613783C3151078OMIM13881247120580
HP:0012115HP:0012115Hepatitis0CYP7A1 CL E G H1581209902ORPHA11452651118455
HP:0012115HP:0012115Hepatitis0CYP7B1 CL E G H9420613812Bile acid synthesis defect, congenital, 3613812C3151147OMIM14152652603711
HP:0012115HP:0012115Hepatitis0GLIS3 CL E G H169792610199Diabetes mellitus, neonatal, with congenital hypothyroidism610199C1857775OMIM168628510610192
HP:0012115HP:0012115Hepatitis0GUSB CL E G H2990584Al Gazali Donnai Mueller syndromeORPHA14144696611499
HP:0012115HP:0012115Hepatitis0PGM1 CL E G H5236614921Congenital disorder of glycosylation type 1t614921C2752015OMIM14138905171900
HP:0012115HP:0012115Hepatitis0SERPINA1 CL E G H526560ORPHA14238941107400
HP:0012115HP:0012115Hepatitis0SHPK CL E G H23729440713ORPHA12321492605060
HP:0012115HP:0012115Hepatitis0SKIV2L CL E G H6499614602Trichohepatoenteric syndrome 2614602C3281289OMIM110898600478
HP:0012115HP:0012115Hepatitis0TPP2 CL E G H7174444463ORPHA162512016190470
HP:0012115HP:0200122Atypical or prolonged hepatitis1ATP7A CL E G H538198ORPHA11751869300011
HP:0012115HP:0200084Giant cell hepatitis1ATP7A CL E G H538198ORPHA11751869300011
HP:0012115HP:0200119Acute hepatitis1ATP7A CL E G H538198ORPHA11751869300011
HP:0012115HP:0004787Fulminant hepatitis1ATP7A CL E G H538198ORPHA11751869300011
HP:0012115HP:0006562Viral hepatitis1ATP7A CL E G H538198ORPHA11751869300011
HP:0012115HP:0200123Chronic hepatitis1ATP7A CL E G H538198ORPHA11751869300011
HP:0012115HP:0032220Interface hepatitis1ATP7A CL E G H538198ORPHA11751869300011
HP:0012115HP:0200122Atypical or prolonged hepatitis1C1S CL E G H716613783Complement component c1s deficiency613783C3151078OMIM13881247120580
HP:0012115HP:0200084Giant cell hepatitis1C1S CL E G H716613783Complement component c1s deficiency613783C3151078OMIM13881247120580
HP:0012115HP:0200119Acute hepatitis1C1S CL E G H716613783Complement component c1s deficiency613783C3151078OMIM13881247120580
HP:0012115HP:0004787Fulminant hepatitis1C1S CL E G H716613783Complement component c1s deficiency613783C3151078OMIM13881247120580
HP:0012115HP:0006562Viral hepatitis1C1S CL E G H716613783Complement component c1s deficiency613783C3151078OMIM13881247120580
HP:0012115HP:0200123Chronic hepatitis1C1S CL E G H716613783Complement component c1s deficiency613783C3151078OMIM13881247120580
HP:0012115HP:0032220Interface hepatitis1C1S CL E G H716613783Complement component c1s deficiency613783C3151078OMIM13881247120580
HP:0012115HP:0200122Atypical or prolonged hepatitis1CYP7A1 CL E G H1581209902ORPHA11452651118455
HP:0012115HP:0200084Giant cell hepatitis1CYP7A1 CL E G H1581209902ORPHA11452651118455
HP:0012115HP:0200119Acute hepatitis1CYP7A1 CL E G H1581209902ORPHA11452651118455
HP:0012115HP:0006562Viral hepatitis1CYP7A1 CL E G H1581209902ORPHA11452651118455
HP:0012115HP:0004787Fulminant hepatitis1CYP7A1 CL E G H1581209902ORPHA11452651118455
HP:0012115HP:0200123Chronic hepatitis1CYP7A1 CL E G H1581209902ORPHA11452651118455
HP:0012115HP:0032220Interface hepatitis1CYP7A1 CL E G H1581209902ORPHA11452651118455
HP:0012115HP:0200122Atypical or prolonged hepatitis1CYP7B1 CL E G H9420613812Bile acid synthesis defect, congenital, 3613812C3151147OMIM14152652603711
HP:0012115HP:0200084Giant cell hepatitis1CYP7B1 CL E G H9420613812Bile acid synthesis defect, congenital, 3613812C3151147OMIM14152652603711
HP:0012115HP:0200119Acute hepatitis1CYP7B1 CL E G H9420613812Bile acid synthesis defect, congenital, 3613812C3151147OMIM14152652603711
HP:0012115HP:0006562Viral hepatitis1CYP7B1 CL E G H9420613812Bile acid synthesis defect, congenital, 3613812C3151147OMIM14152652603711
HP:0012115HP:0004787Fulminant hepatitis1CYP7B1 CL E G H9420613812Bile acid synthesis defect, congenital, 3613812C3151147OMIM14152652603711
HP:0012115HP:0200123Chronic hepatitis1CYP7B1 CL E G H9420613812Bile acid synthesis defect, congenital, 3613812C3151147OMIM14152652603711
HP:0012115HP:0032220Interface hepatitis1CYP7B1 CL E G H9420613812Bile acid synthesis defect, congenital, 3613812C3151147OMIM14152652603711
HP:0012115HP:0200084Giant cell hepatitis1GLIS3 CL E G H169792610199Diabetes mellitus, neonatal, with congenital hypothyroidism610199C1857775OMIM168628510610192
HP:0012115HP:0200122Atypical or prolonged hepatitis1GLIS3 CL E G H169792610199Diabetes mellitus, neonatal, with congenital hypothyroidism610199C1857775OMIM168628510610192
HP:0012115HP:0200119Acute hepatitis1GLIS3 CL E G H169792610199Diabetes mellitus, neonatal, with congenital hypothyroidism610199C1857775OMIM168628510610192
HP:0012115HP:0006562Viral hepatitis1GLIS3 CL E G H169792610199Diabetes mellitus, neonatal, with congenital hypothyroidism610199C1857775OMIM168628510610192
HP:0012115HP:0004787Fulminant hepatitis1GLIS3 CL E G H169792610199Diabetes mellitus, neonatal, with congenital hypothyroidism610199C1857775OMIM168628510610192
HP:0012115HP:0032220Interface hepatitis1GLIS3 CL E G H169792610199Diabetes mellitus, neonatal, with congenital hypothyroidism610199C1857775OMIM168628510610192
HP:0012115HP:0200123Chronic hepatitis1GLIS3 CL E G H169792610199Diabetes mellitus, neonatal, with congenital hypothyroidism610199C1857775OMIM168628510610192
HP:0012115HP:0200122Atypical or prolonged hepatitis1GUSB CL E G H2990584Al Gazali Donnai Mueller syndromeORPHA14144696611499
HP:0012115HP:0200084Giant cell hepatitis1GUSB CL E G H2990584Al Gazali Donnai Mueller syndromeORPHA14144696611499
HP:0012115HP:0200119Acute hepatitis1GUSB CL E G H2990584Al Gazali Donnai Mueller syndromeORPHA14144696611499
HP:0012115HP:0006562Viral hepatitis1GUSB CL E G H2990584Al Gazali Donnai Mueller syndromeORPHA14144696611499
HP:0012115HP:0004787Fulminant hepatitis1GUSB CL E G H2990584Al Gazali Donnai Mueller syndromeORPHA14144696611499
HP:0012115HP:0200123Chronic hepatitis1GUSB CL E G H2990584Al Gazali Donnai Mueller syndromeORPHA14144696611499
HP:0012115HP:0032220Interface hepatitis1GUSB CL E G H2990584Al Gazali Donnai Mueller syndromeORPHA14144696611499
HP:0012115HP:0200122Atypical or prolonged hepatitis1PGM1 CL E G H5236614921Congenital disorder of glycosylation type 1t614921C2752015OMIM14138905171900
HP:0012115HP:0200084Giant cell hepatitis1PGM1 CL E G H5236614921Congenital disorder of glycosylation type 1t614921C2752015OMIM14138905171900
HP:0012115HP:0200119Acute hepatitis1PGM1 CL E G H5236614921Congenital disorder of glycosylation type 1t614921C2752015OMIM14138905171900
HP:0012115HP:0004787Fulminant hepatitis1PGM1 CL E G H5236614921Congenital disorder of glycosylation type 1t614921C2752015OMIM14138905171900
HP:0012115HP:0006562Viral hepatitis1PGM1 CL E G H5236614921Congenital disorder of glycosylation type 1t614921C2752015OMIM14138905171900
HP:0012115HP:0200123Chronic hepatitis1PGM1 CL E G H5236614921Congenital disorder of glycosylation type 1t614921C2752015OMIM14138905171900
HP:0012115HP:0032220Interface hepatitis1PGM1 CL E G H5236614921Congenital disorder of glycosylation type 1t614921C2752015OMIM14138905171900
HP:0012115HP:0200122Atypical or prolonged hepatitis1SERPINA1 CL E G H526560ORPHA14238941107400
HP:0012115HP:0200084Giant cell hepatitis1SERPINA1 CL E G H526560ORPHA14238941107400
HP:0012115HP:0200119Acute hepatitis1SERPINA1 CL E G H526560ORPHA14238941107400
HP:0012115HP:0004787Fulminant hepatitis1SERPINA1 CL E G H526560ORPHA14238941107400
HP:0012115HP:0006562Viral hepatitis1SERPINA1 CL E G H526560ORPHA14238941107400
HP:0012115HP:0200123Chronic hepatitis1SERPINA1 CL E G H526560ORPHA14238941107400
HP:0012115HP:0032220Interface hepatitis1SERPINA1 CL E G H526560ORPHA14238941107400
HP:0012115HP:0200122Atypical or prolonged hepatitis1SHPK CL E G H23729440713ORPHA12321492605060
HP:0012115HP:0200119Acute hepatitis1SHPK CL E G H23729440713ORPHA12321492605060
HP:0012115HP:0006562Viral hepatitis1SHPK CL E G H23729440713ORPHA12321492605060
HP:0012115HP:0004787Fulminant hepatitis1SHPK CL E G H23729440713ORPHA12321492605060
HP:0012115HP:0032220Interface hepatitis1SHPK CL E G H23729440713ORPHA12321492605060
HP:0012115HP:0200123Chronic hepatitis1SHPK CL E G H23729440713ORPHA12321492605060
HP:0012115HP:0200084Giant cell hepatitis1SHPK CL E G H23729440713ORPHA12321492605060
HP:0012115HP:0200122Atypical or prolonged hepatitis1SKIV2L CL E G H6499614602Trichohepatoenteric syndrome 2614602C3281289OMIM110898600478
HP:0012115HP:0200084Giant cell hepatitis1SKIV2L CL E G H6499614602Trichohepatoenteric syndrome 2614602C3281289OMIM110898600478
HP:0012115HP:0200119Acute hepatitis1SKIV2L CL E G H6499614602Trichohepatoenteric syndrome 2614602C3281289OMIM110898600478
HP:0012115HP:0006562Viral hepatitis1SKIV2L CL E G H6499614602Trichohepatoenteric syndrome 2614602C3281289OMIM110898600478
HP:0012115HP:0004787Fulminant hepatitis1SKIV2L CL E G H6499614602Trichohepatoenteric syndrome 2614602C3281289OMIM110898600478
HP:0012115HP:0032220Interface hepatitis1SKIV2L CL E G H6499614602Trichohepatoenteric syndrome 2614602C3281289OMIM110898600478
HP:0012115HP:0200123Chronic hepatitis1SKIV2L CL E G H6499614602Trichohepatoenteric syndrome 2614602C3281289OMIM110898600478
HP:0012115HP:0200119Acute hepatitis1TPP2 CL E G H7174444463ORPHA162512016190470
HP:0012115HP:0004787Fulminant hepatitis1TPP2 CL E G H7174444463ORPHA162512016190470
HP:0012115HP:0006562Viral hepatitis1TPP2 CL E G H7174444463ORPHA162512016190470
HP:0012115HP:0200123Chronic hepatitis1TPP2 CL E G H7174444463ORPHA162512016190470
HP:0012115HP:0032220Interface hepatitis1TPP2 CL E G H7174444463ORPHA162512016190470
HP:0012115HP:0200122Atypical or prolonged hepatitis1TPP2 CL E G H7174444463ORPHA162512016190470
HP:0012115HP:0200084Giant cell hepatitis1TPP2 CL E G H7174444463ORPHA162512016190470
HP:0012115HP:0006572Subacute progressive viral hepatitis2ATP7A CL E G H538198ORPHA11751869300011
HP:0012115HP:0200124Chronic hepatitis due to cryptosporidium infection2ATP7A CL E G H538198ORPHA11751869300011
HP:0012115HP:0001412Enteroviral hepatitis2ATP7A CL E G H538198ORPHA11751869300011
HP:0012115HP:0200120Chronic active hepatitis2ATP7A CL E G H538198ORPHA11751869300011
HP:0012115HP:0006572Subacute progressive viral hepatitis2C1S CL E G H716613783Complement component c1s deficiency613783C3151078OMIM13881247120580
HP:0012115HP:0200124Chronic hepatitis due to cryptosporidium infection2C1S CL E G H716613783Complement component c1s deficiency613783C3151078OMIM13881247120580
HP:0012115HP:0001412Enteroviral hepatitis2C1S CL E G H716613783Complement component c1s deficiency613783C3151078OMIM13881247120580
HP:0012115HP:0200120Chronic active hepatitis2C1S CL E G H716613783Complement component c1s deficiency613783C3151078OMIM13881247120580
HP:0012115HP:0006572Subacute progressive viral hepatitis2CYP7A1 CL E G H1581209902ORPHA11452651118455
HP:0012115HP:0001412Enteroviral hepatitis2CYP7A1 CL E G H1581209902ORPHA11452651118455
HP:0012115HP:0200124Chronic hepatitis due to cryptosporidium infection2CYP7A1 CL E G H1581209902ORPHA11452651118455
HP:0012115HP:0200120Chronic active hepatitis2CYP7A1 CL E G H1581209902ORPHA11452651118455
HP:0012115HP:0006572Subacute progressive viral hepatitis2CYP7B1 CL E G H9420613812Bile acid synthesis defect, congenital, 3613812C3151147OMIM14152652603711
HP:0012115HP:0200124Chronic hepatitis due to cryptosporidium infection2CYP7B1 CL E G H9420613812Bile acid synthesis defect, congenital, 3613812C3151147OMIM14152652603711
HP:0012115HP:0001412Enteroviral hepatitis2CYP7B1 CL E G H9420613812Bile acid synthesis defect, congenital, 3613812C3151147OMIM14152652603711
HP:0012115HP:0200120Chronic active hepatitis2CYP7B1 CL E G H9420613812Bile acid synthesis defect, congenital, 3613812C3151147OMIM14152652603711
HP:0012115HP:0006572Subacute progressive viral hepatitis2GLIS3 CL E G H169792610199Diabetes mellitus, neonatal, with congenital hypothyroidism610199C1857775OMIM168628510610192
HP:0012115HP:0001412Enteroviral hepatitis2GLIS3 CL E G H169792610199Diabetes mellitus, neonatal, with congenital hypothyroidism610199C1857775OMIM168628510610192
HP:0012115HP:0200124Chronic hepatitis due to cryptosporidium infection2GLIS3 CL E G H169792610199Diabetes mellitus, neonatal, with congenital hypothyroidism610199C1857775OMIM168628510610192
HP:0012115HP:0200120Chronic active hepatitis2GLIS3 CL E G H169792610199Diabetes mellitus, neonatal, with congenital hypothyroidism610199C1857775OMIM168628510610192
HP:0012115HP:0006572Subacute progressive viral hepatitis2GUSB CL E G H2990584Al Gazali Donnai Mueller syndromeORPHA14144696611499
HP:0012115HP:0200124Chronic hepatitis due to cryptosporidium infection2GUSB CL E G H2990584Al Gazali Donnai Mueller syndromeORPHA14144696611499
HP:0012115HP:0001412Enteroviral hepatitis2GUSB CL E G H2990584Al Gazali Donnai Mueller syndromeORPHA14144696611499
HP:0012115HP:0200120Chronic active hepatitis2GUSB CL E G H2990584Al Gazali Donnai Mueller syndromeORPHA14144696611499
HP:0012115HP:0006572Subacute progressive viral hepatitis2PGM1 CL E G H5236614921Congenital disorder of glycosylation type 1t614921C2752015OMIM14138905171900
HP:0012115HP:0200124Chronic hepatitis due to cryptosporidium infection2PGM1 CL E G H5236614921Congenital disorder of glycosylation type 1t614921C2752015OMIM14138905171900
HP:0012115HP:0001412Enteroviral hepatitis2PGM1 CL E G H5236614921Congenital disorder of glycosylation type 1t614921C2752015OMIM14138905171900
HP:0012115HP:0200120Chronic active hepatitis2PGM1 CL E G H5236614921Congenital disorder of glycosylation type 1t614921C2752015OMIM14138905171900
HP:0012115HP:0006572Subacute progressive viral hepatitis2SERPINA1 CL E G H526560ORPHA14238941107400
HP:0012115HP:0001412Enteroviral hepatitis2SERPINA1 CL E G H526560ORPHA14238941107400
HP:0012115HP:0200124Chronic hepatitis due to cryptosporidium infection2SERPINA1 CL E G H526560ORPHA14238941107400
HP:0012115HP:0200120Chronic active hepatitis2SERPINA1 CL E G H526560ORPHA14238941107400
HP:0012115HP:0200124Chronic hepatitis due to cryptosporidium infection2SHPK CL E G H23729440713ORPHA12321492605060
HP:0012115HP:0001412Enteroviral hepatitis2SHPK CL E G H23729440713ORPHA12321492605060
HP:0012115HP:0200120Chronic active hepatitis2SHPK CL E G H23729440713ORPHA12321492605060
HP:0012115HP:0006572Subacute progressive viral hepatitis2SHPK CL E G H23729440713ORPHA12321492605060
HP:0012115HP:0006572Subacute progressive viral hepatitis2SKIV2L CL E G H6499614602Trichohepatoenteric syndrome 2614602C3281289OMIM110898600478
HP:0012115HP:0001412Enteroviral hepatitis2SKIV2L CL E G H6499614602Trichohepatoenteric syndrome 2614602C3281289OMIM110898600478
HP:0012115HP:0200124Chronic hepatitis due to cryptosporidium infection2SKIV2L CL E G H6499614602Trichohepatoenteric syndrome 2614602C3281289OMIM110898600478
HP:0012115HP:0200120Chronic active hepatitis2SKIV2L CL E G H6499614602Trichohepatoenteric syndrome 2614602C3281289OMIM110898600478
HP:0012115HP:0001412Enteroviral hepatitis2TPP2 CL E G H7174444463ORPHA162512016190470
HP:0012115HP:0200124Chronic hepatitis due to cryptosporidium infection2TPP2 CL E G H7174444463ORPHA162512016190470
HP:0012115HP:0200120Chronic active hepatitis2TPP2 CL E G H7174444463ORPHA162512016190470
HP:0012115HP:0006572Subacute progressive viral hepatitis2TPP2 CL E G H7174444463ORPHA162512016190470
 
HPO disease - gene - phenotype less frequent non-typical associations:
HP:0012115HP:0012115Hepatitis0BLNK CL E G H2976033110ORPHA029614211604515
HP:0012115HP:0012115Hepatitis0BTK CL E G H69547ORPHA06751133300300
HP:0012115HP:0012115Hepatitis0CD79A CL E G H97333110ORPHA01501698112205
HP:0012115HP:0012115Hepatitis0CD79B CL E G H97433110ORPHA01611699147245
HP:0012115HP:0012115Hepatitis0CLEC7A CL E G H645811334ORPHA05714558606264
HP:0012115HP:0012115Hepatitis0GPR35 CL E G H2859171Le Marec Bracq Picaud syndromeORPHA01394492602646
HP:0012115HP:0012115Hepatitis0IGHM CL E G H350733110ORPHA0835541147020
HP:0012115HP:0012115Hepatitis0IGLL1 CL E G H354333110ORPHA03105870146770
HP:0012115HP:0012115Hepatitis0IL12A CL E G H3592186ORPHA0345969161560
HP:0012115HP:0012115Hepatitis0IL12RB1 CL E G H3594186ORPHA04655971601604
HP:0012115HP:0012115Hepatitis0IL17F CL E G H1127441334ORPHA013216404606496
HP:0012115HP:0012115Hepatitis0IL17RA CL E G H237651334ORPHA08885985605461
HP:0012115HP:0012115Hepatitis0IL17RC CL E G H848181334ORPHA058218358610925
HP:0012115HP:0012115Hepatitis0IRF5 CL E G H3663186ORPHA0656120607218
HP:0012115HP:0012115Hepatitis0LRRC8A CL E G H5626233110ORPHA032119027608360
HP:0012115HP:0012115Hepatitis0MMEL1 CL E G H79258186ORPHA018114668618104
HP:0012115HP:0012115Hepatitis0MST1 CL E G H4485171Le Marec Bracq Picaud syndromeORPHA0577380142408
HP:0012115HP:0012115Hepatitis0PIEZO1 CL E G H9780194380Xerocytosis194380C0272051OMIM0143328993611184
HP:0012115HP:0012115Hepatitis0PIK3R1 CL E G H529533110ORPHA04578979171833
HP:0012115HP:0012115Hepatitis0POU2AF1 CL E G H5450186ORPHA0399211601206
HP:0012115HP:0012115Hepatitis0SPIB CL E G H6689186ORPHA03411242606802
HP:0012115HP:0012115Hepatitis0STAT1 CL E G H6772391487ORPHA055711362600555
HP:0012115HP:0012115Hepatitis0TBX19 CL E G H9095199296ORPHA016511596604614
HP:0012115HP:0012115Hepatitis0TCF3 CL E G H692933110ORPHA074411633147141
HP:0012115HP:0012115Hepatitis0TCF4 CL E G H6925171Le Marec Bracq Picaud syndromeORPHA0106911634602272
HP:0012115HP:0012115Hepatitis0TNFSF15 CL E G H9966186ORPHA05011931604052
HP:0012115HP:0012115Hepatitis0TNPO3 CL E G H23534186ORPHA057517103610032
HP:0012115HP:0012115Hepatitis0TRAF3IP2 CL E G H107581334ORPHA02461343607043
HP:0012115HP:0012115Hepatitis0TTC7A CL E G H57217436252ORPHA092719750609332
HP:0012115HP:0012115Hepatitis0XIAP CL E G H331300635Lymphoproliferative syndrome 2, X-linked300635C1845076OMIM0502592300079
HP:0012115HP:0200084Giant cell hepatitis1BLNK CL E G H2976033110ORPHA029614211604515
HP:0012115HP:0200122Atypical or prolonged hepatitis1BLNK CL E G H2976033110ORPHA029614211604515
HP:0012115HP:0200119Acute hepatitis1BLNK CL E G H2976033110ORPHA029614211604515
HP:0012115HP:0006562Viral hepatitis1BLNK CL E G H2976033110ORPHA029614211604515
HP:0012115HP:0004787Fulminant hepatitis1BLNK CL E G H2976033110ORPHA029614211604515
HP:0012115HP:0032220Interface hepatitis1BLNK CL E G H2976033110ORPHA029614211604515
HP:0012115HP:0200123Chronic hepatitis1BLNK CL E G H2976033110ORPHA029614211604515
HP:0012115HP:0200122Atypical or prolonged hepatitis1BTK CL E G H69547ORPHA06751133300300
HP:0012115HP:0200084Giant cell hepatitis1BTK CL E G H69547ORPHA06751133300300
HP:0012115HP:0200119Acute hepatitis1BTK CL E G H69547ORPHA06751133300300
HP:0012115HP:0006562Viral hepatitis1BTK CL E G H69547ORPHA06751133300300
HP:0012115HP:0004787Fulminant hepatitis1BTK CL E G H69547ORPHA06751133300300
HP:0012115HP:0200123Chronic hepatitis1BTK CL E G H69547ORPHA06751133300300
HP:0012115HP:0032220Interface hepatitis1BTK CL E G H69547ORPHA06751133300300
HP:0012115HP:0200122Atypical or prolonged hepatitis1CD79A CL E G H97333110ORPHA01501698112205
HP:0012115HP:0200084Giant cell hepatitis1CD79A CL E G H97333110ORPHA01501698112205
HP:0012115HP:0200119Acute hepatitis1CD79A CL E G H97333110ORPHA01501698112205
HP:0012115HP:0004787Fulminant hepatitis1CD79A CL E G H97333110ORPHA01501698112205
HP:0012115HP:0006562Viral hepatitis1CD79A CL E G H97333110ORPHA01501698112205
HP:0012115HP:0200123Chronic hepatitis1CD79A CL E G H97333110ORPHA01501698112205
HP:0012115HP:0032220Interface hepatitis1CD79A CL E G H97333110ORPHA01501698112205
HP:0012115HP:0200122Atypical or prolonged hepatitis1CD79B CL E G H97433110ORPHA01611699147245
HP:0012115HP:0200084Giant cell hepatitis1CD79B CL E G H97433110ORPHA01611699147245
HP:0012115HP:0200119Acute hepatitis1CD79B CL E G H97433110ORPHA01611699147245
HP:0012115HP:0004787Fulminant hepatitis1CD79B CL E G H97433110ORPHA01611699147245
HP:0012115HP:0006562Viral hepatitis1CD79B CL E G H97433110ORPHA01611699147245
HP:0012115HP:0200123Chronic hepatitis1CD79B CL E G H97433110ORPHA01611699147245
HP:0012115HP:0032220Interface hepatitis1CD79B CL E G H97433110ORPHA01611699147245
HP:0012115HP:0200122Atypical or prolonged hepatitis1CLEC7A CL E G H645811334ORPHA05714558606264
HP:0012115HP:0200084Giant cell hepatitis1CLEC7A CL E G H645811334ORPHA05714558606264
HP:0012115HP:0200119Acute hepatitis1CLEC7A CL E G H645811334ORPHA05714558606264
HP:0012115HP:0006562Viral hepatitis1CLEC7A CL E G H645811334ORPHA05714558606264
HP:0012115HP:0004787Fulminant hepatitis1CLEC7A CL E G H645811334ORPHA05714558606264
HP:0012115HP:0200123Chronic hepatitis1CLEC7A CL E G H645811334ORPHA05714558606264
HP:0012115HP:0032220Interface hepatitis1CLEC7A CL E G H645811334ORPHA05714558606264
HP:0012115HP:0200122Atypical or prolonged hepatitis1GPR35 CL E G H2859171Le Marec Bracq Picaud syndromeORPHA01394492602646
HP:0012115HP:0200084Giant cell hepatitis1GPR35 CL E G H2859171Le Marec Bracq Picaud syndromeORPHA01394492602646
HP:0012115HP:0200119Acute hepatitis1GPR35 CL E G H2859171Le Marec Bracq Picaud syndromeORPHA01394492602646
HP:0012115HP:0004787Fulminant hepatitis1GPR35 CL E G H2859171Le Marec Bracq Picaud syndromeORPHA01394492602646
HP:0012115HP:0006562Viral hepatitis1GPR35 CL E G H2859171Le Marec Bracq Picaud syndromeORPHA01394492602646
HP:0012115HP:0200123Chronic hepatitis1GPR35 CL E G H2859171Le Marec Bracq Picaud syndromeORPHA01394492602646
HP:0012115HP:0032220Interface hepatitis1GPR35 CL E G H2859171Le Marec Bracq Picaud syndromeORPHA01394492602646
HP:0012115HP:0200084Giant cell hepatitis1IGHM CL E G H350733110ORPHA0835541147020
HP:0012115HP:0200122Atypical or prolonged hepatitis1IGHM CL E G H350733110ORPHA0835541147020
HP:0012115HP:0200119Acute hepatitis1IGHM CL E G H350733110ORPHA0835541147020
HP:0012115HP:0006562Viral hepatitis1IGHM CL E G H350733110ORPHA0835541147020
HP:0012115HP:0004787Fulminant hepatitis1IGHM CL E G H350733110ORPHA0835541147020
HP:0012115HP:0032220Interface hepatitis1IGHM CL E G H350733110ORPHA0835541147020
HP:0012115HP:0200123Chronic hepatitis1IGHM CL E G H350733110ORPHA0835541147020
HP:0012115HP:0200122Atypical or prolonged hepatitis1IGLL1 CL E G H354333110ORPHA03105870146770
HP:0012115HP:0200084Giant cell hepatitis1IGLL1 CL E G H354333110ORPHA03105870146770
HP:0012115HP:0200119Acute hepatitis1IGLL1 CL E G H354333110ORPHA03105870146770
HP:0012115HP:0004787Fulminant hepatitis1IGLL1 CL E G H354333110ORPHA03105870146770
HP:0012115HP:0006562Viral hepatitis1IGLL1 CL E G H354333110ORPHA03105870146770
HP:0012115HP:0200123Chronic hepatitis1IGLL1 CL E G H354333110ORPHA03105870146770
HP:0012115HP:0032220Interface hepatitis1IGLL1 CL E G H354333110ORPHA03105870146770
HP:0012115HP:0200122Atypical or prolonged hepatitis1IL12A CL E G H3592186ORPHA0345969161560
HP:0012115HP:0200084Giant cell hepatitis1IL12A CL E G H3592186ORPHA0345969161560
HP:0012115HP:0200119Acute hepatitis1IL12A CL E G H3592186ORPHA0345969161560
HP:0012115HP:0004787Fulminant hepatitis1IL12A CL E G H3592186ORPHA0345969161560
HP:0012115HP:0006562Viral hepatitis1IL12A CL E G H3592186ORPHA0345969161560
HP:0012115HP:0200123Chronic hepatitis1IL12A CL E G H3592186ORPHA0345969161560
HP:0012115HP:0032220Interface hepatitis1IL12A CL E G H3592186ORPHA0345969161560
HP:0012115HP:0200084Giant cell hepatitis1IL12RB1 CL E G H3594186ORPHA04655971601604
HP:0012115HP:0200122Atypical or prolonged hepatitis1IL12RB1 CL E G H3594186ORPHA04655971601604
HP:0012115HP:0200119Acute hepatitis1IL12RB1 CL E G H3594186ORPHA04655971601604
HP:0012115HP:0006562Viral hepatitis1IL12RB1 CL E G H3594186ORPHA04655971601604
HP:0012115HP:0004787Fulminant hepatitis1IL12RB1 CL E G H3594186ORPHA04655971601604
HP:0012115HP:0032220Interface hepatitis1IL12RB1 CL E G H3594186ORPHA04655971601604
HP:0012115HP:0200123Chronic hepatitis1IL12RB1 CL E G H3594186ORPHA04655971601604
HP:0012115HP:0200122Atypical or prolonged hepatitis1IL17F CL E G H1127441334ORPHA013216404606496
HP:0012115HP:0200084Giant cell hepatitis1IL17F CL E G H1127441334ORPHA013216404606496
HP:0012115HP:0200119Acute hepatitis1IL17F CL E G H1127441334ORPHA013216404606496
HP:0012115HP:0004787Fulminant hepatitis1IL17F CL E G H1127441334ORPHA013216404606496
HP:0012115HP:0006562Viral hepatitis1IL17F CL E G H1127441334ORPHA013216404606496
HP:0012115HP:0200123Chronic hepatitis1IL17F CL E G H1127441334ORPHA013216404606496
HP:0012115HP:0032220Interface hepatitis1IL17F CL E G H1127441334ORPHA013216404606496
HP:0012115HP:0200084Giant cell hepatitis1IL17RA CL E G H237651334ORPHA08885985605461
HP:0012115HP:0200122Atypical or prolonged hepatitis1IL17RA CL E G H237651334ORPHA08885985605461
HP:0012115HP:0200119Acute hepatitis1IL17RA CL E G H237651334ORPHA08885985605461
HP:0012115HP:0006562Viral hepatitis1IL17RA CL E G H237651334ORPHA08885985605461
HP:0012115HP:0004787Fulminant hepatitis1IL17RA CL E G H237651334ORPHA08885985605461
HP:0012115HP:0200123Chronic hepatitis1IL17RA CL E G H237651334ORPHA08885985605461
HP:0012115HP:0032220Interface hepatitis1IL17RA CL E G H237651334ORPHA08885985605461
HP:0012115HP:0200122Atypical or prolonged hepatitis1IL17RC CL E G H848181334ORPHA058218358610925
HP:0012115HP:0200084Giant cell hepatitis1IL17RC CL E G H848181334ORPHA058218358610925
HP:0012115HP:0200119Acute hepatitis1IL17RC CL E G H848181334ORPHA058218358610925
HP:0012115HP:0004787Fulminant hepatitis1IL17RC CL E G H848181334ORPHA058218358610925
HP:0012115HP:0006562Viral hepatitis1IL17RC CL E G H848181334ORPHA058218358610925
HP:0012115HP:0200123Chronic hepatitis1IL17RC CL E G H848181334ORPHA058218358610925
HP:0012115HP:0032220Interface hepatitis1IL17RC CL E G H848181334ORPHA058218358610925
HP:0012115HP:0200122Atypical or prolonged hepatitis1IRF5 CL E G H3663186ORPHA0656120607218
HP:0012115HP:0200084Giant cell hepatitis1IRF5 CL E G H3663186ORPHA0656120607218
HP:0012115HP:0200119Acute hepatitis1IRF5 CL E G H3663186ORPHA0656120607218
HP:0012115HP:0004787Fulminant hepatitis1IRF5 CL E G H3663186ORPHA0656120607218
HP:0012115HP:0006562Viral hepatitis1IRF5 CL E G H3663186ORPHA0656120607218
HP:0012115HP:0200123Chronic hepatitis1IRF5 CL E G H3663186ORPHA0656120607218
HP:0012115HP:0032220Interface hepatitis1IRF5 CL E G H3663186ORPHA0656120607218
HP:0012115HP:0200122Atypical or prolonged hepatitis1LRRC8A CL E G H5626233110ORPHA032119027608360
HP:0012115HP:0200084Giant cell hepatitis1LRRC8A CL E G H5626233110ORPHA032119027608360
HP:0012115HP:0200119Acute hepatitis1LRRC8A CL E G H5626233110ORPHA032119027608360
HP:0012115HP:0004787Fulminant hepatitis1LRRC8A CL E G H5626233110ORPHA032119027608360
HP:0012115HP:0006562Viral hepatitis1LRRC8A CL E G H5626233110ORPHA032119027608360
HP:0012115HP:0200123Chronic hepatitis1LRRC8A CL E G H5626233110ORPHA032119027608360
HP:0012115HP:0032220Interface hepatitis1LRRC8A CL E G H5626233110ORPHA032119027608360
HP:0012115HP:0200122Atypical or prolonged hepatitis1MMEL1 CL E G H79258186ORPHA018114668618104
HP:0012115HP:0200084Giant cell hepatitis1MMEL1 CL E G H79258186ORPHA018114668618104
HP:0012115HP:0200119Acute hepatitis1MMEL1 CL E G H79258186ORPHA018114668618104
HP:0012115HP:0004787Fulminant hepatitis1MMEL1 CL E G H79258186ORPHA018114668618104
HP:0012115HP:0006562Viral hepatitis1MMEL1 CL E G H79258186ORPHA018114668618104
HP:0012115HP:0200123Chronic hepatitis1MMEL1 CL E G H79258186ORPHA018114668618104
HP:0012115HP:0032220Interface hepatitis1MMEL1 CL E G H79258186ORPHA018114668618104
HP:0012115HP:0200084Giant cell hepatitis1MST1 CL E G H4485171Le Marec Bracq Picaud syndromeORPHA0577380142408
HP:0012115HP:0200122Atypical or prolonged hepatitis1MST1 CL E G H4485171Le Marec Bracq Picaud syndromeORPHA0577380142408
HP:0012115HP:0200119Acute hepatitis1MST1 CL E G H4485171Le Marec Bracq Picaud syndromeORPHA0577380142408
HP:0012115HP:0006562Viral hepatitis1MST1 CL E G H4485171Le Marec Bracq Picaud syndromeORPHA0577380142408
HP:0012115HP:0004787Fulminant hepatitis1MST1 CL E G H4485171Le Marec Bracq Picaud syndromeORPHA0577380142408
HP:0012115HP:0200123Chronic hepatitis1MST1 CL E G H4485171Le Marec Bracq Picaud syndromeORPHA0577380142408
HP:0012115HP:0032220Interface hepatitis1MST1 CL E G H4485171Le Marec Bracq Picaud syndromeORPHA0577380142408
HP:0012115HP:0200122Atypical or prolonged hepatitis1PIEZO1 CL E G H9780194380Xerocytosis194380C0272051OMIM0143328993611184
HP:0012115HP:0200084Giant cell hepatitis1PIEZO1 CL E G H9780194380Xerocytosis194380C0272051OMIM0143328993611184
HP:0012115HP:0200119Acute hepatitis1PIEZO1 CL E G H9780194380Xerocytosis194380C0272051OMIM0143328993611184
HP:0012115HP:0004787Fulminant hepatitis1PIEZO1 CL E G H9780194380Xerocytosis194380C0272051OMIM0143328993611184
HP:0012115HP:0006562Viral hepatitis1PIEZO1 CL E G H9780194380Xerocytosis194380C0272051OMIM0143328993611184
HP:0012115HP:0200123Chronic hepatitis1PIEZO1 CL E G H9780194380Xerocytosis194380C0272051OMIM0143328993611184
HP:0012115HP:0032220Interface hepatitis1PIEZO1 CL E G H9780194380Xerocytosis194380C0272051OMIM0143328993611184
HP:0012115HP:0200084Giant cell hepatitis1PIK3R1 CL E G H529533110ORPHA04578979171833
HP:0012115HP:0200122Atypical or prolonged hepatitis1PIK3R1 CL E G H529533110ORPHA04578979171833
HP:0012115HP:0200119Acute hepatitis1PIK3R1 CL E G H529533110ORPHA04578979171833
HP:0012115HP:0006562Viral hepatitis1PIK3R1 CL E G H529533110ORPHA04578979171833
HP:0012115HP:0004787Fulminant hepatitis1PIK3R1 CL E G H529533110ORPHA04578979171833
HP:0012115HP:0032220Interface hepatitis1PIK3R1 CL E G H529533110ORPHA04578979171833
HP:0012115HP:0200123Chronic hepatitis1PIK3R1 CL E G H529533110ORPHA04578979171833
HP:0012115HP:0200084Giant cell hepatitis1POU2AF1 CL E G H5450186ORPHA0399211601206
HP:0012115HP:0200122Atypical or prolonged hepatitis1POU2AF1 CL E G H5450186ORPHA0399211601206
HP:0012115HP:0200119Acute hepatitis1POU2AF1 CL E G H5450186ORPHA0399211601206
HP:0012115HP:0006562Viral hepatitis1POU2AF1 CL E G H5450186ORPHA0399211601206
HP:0012115HP:0004787Fulminant hepatitis1POU2AF1 CL E G H5450186ORPHA0399211601206
HP:0012115HP:0032220Interface hepatitis1POU2AF1 CL E G H5450186ORPHA0399211601206
HP:0012115HP:0200123Chronic hepatitis1POU2AF1 CL E G H5450186ORPHA0399211601206
HP:0012115HP:0200122Atypical or prolonged hepatitis1SPIB CL E G H6689186ORPHA03411242606802
HP:0012115HP:0200084Giant cell hepatitis1SPIB CL E G H6689186ORPHA03411242606802
HP:0012115HP:0200119Acute hepatitis1SPIB CL E G H6689186ORPHA03411242606802
HP:0012115HP:0004787Fulminant hepatitis1SPIB CL E G H6689186ORPHA03411242606802
HP:0012115HP:0006562Viral hepatitis1SPIB CL E G H6689186ORPHA03411242606802
HP:0012115HP:0200123Chronic hepatitis1SPIB CL E G H6689186ORPHA03411242606802
HP:0012115HP:0032220Interface hepatitis1SPIB CL E G H6689186ORPHA03411242606802
HP:0012115HP:0200122Atypical or prolonged hepatitis1STAT1 CL E G H6772391487ORPHA055711362600555
HP:0012115HP:0200084Giant cell hepatitis1STAT1 CL E G H6772391487ORPHA055711362600555
HP:0012115HP:0200119Acute hepatitis1STAT1 CL E G H6772391487ORPHA055711362600555
HP:0012115HP:0004787Fulminant hepatitis1STAT1 CL E G H6772391487ORPHA055711362600555
HP:0012115HP:0006562Viral hepatitis1STAT1 CL E G H6772391487ORPHA055711362600555
HP:0012115HP:0200123Chronic hepatitis1STAT1 CL E G H6772391487ORPHA055711362600555
HP:0012115HP:0032220Interface hepatitis1STAT1 CL E G H6772391487ORPHA055711362600555
HP:0012115HP:0200122Atypical or prolonged hepatitis1TBX19 CL E G H9095199296ORPHA016511596604614
HP:0012115HP:0200084Giant cell hepatitis1TBX19 CL E G H9095199296ORPHA016511596604614
HP:0012115HP:0200119Acute hepatitis1TBX19 CL E G H9095199296ORPHA016511596604614
HP:0012115HP:0006562Viral hepatitis1TBX19 CL E G H9095199296ORPHA016511596604614
HP:0012115HP:0004787Fulminant hepatitis1TBX19 CL E G H9095199296ORPHA016511596604614
HP:0012115HP:0200123Chronic hepatitis1TBX19 CL E G H9095199296ORPHA016511596604614
HP:0012115HP:0032220Interface hepatitis1TBX19 CL E G H9095199296ORPHA016511596604614
HP:0012115HP:0200122Atypical or prolonged hepatitis1TCF3 CL E G H692933110ORPHA074411633147141
HP:0012115HP:0200084Giant cell hepatitis1TCF3 CL E G H692933110ORPHA074411633147141
HP:0012115HP:0200119Acute hepatitis1TCF3 CL E G H692933110ORPHA074411633147141
HP:0012115HP:0004787Fulminant hepatitis1TCF3 CL E G H692933110ORPHA074411633147141
HP:0012115HP:0006562Viral hepatitis1TCF3 CL E G H692933110ORPHA074411633147141
HP:0012115HP:0200123Chronic hepatitis1TCF3 CL E G H692933110ORPHA074411633147141
HP:0012115HP:0032220Interface hepatitis1TCF3 CL E G H692933110ORPHA074411633147141
HP:0012115HP:0200122Atypical or prolonged hepatitis1TCF4 CL E G H6925171Le Marec Bracq Picaud syndromeORPHA0106911634602272
HP:0012115HP:0200084Giant cell hepatitis1TCF4 CL E G H6925171Le Marec Bracq Picaud syndromeORPHA0106911634602272
HP:0012115HP:0200119Acute hepatitis1TCF4 CL E G H6925171Le Marec Bracq Picaud syndromeORPHA0106911634602272
HP:0012115HP:0004787Fulminant hepatitis1TCF4 CL E G H6925171Le Marec Bracq Picaud syndromeORPHA0106911634602272
HP:0012115HP:0006562Viral hepatitis1TCF4 CL E G H6925171Le Marec Bracq Picaud syndromeORPHA0106911634602272
HP:0012115HP:0200123Chronic hepatitis1TCF4 CL E G H6925171Le Marec Bracq Picaud syndromeORPHA0106911634602272
HP:0012115HP:0032220Interface hepatitis1TCF4 CL E G H6925171Le Marec Bracq Picaud syndromeORPHA0106911634602272
HP:0012115HP:0200122Atypical or prolonged hepatitis1TNFSF15 CL E G H9966186ORPHA05011931604052
HP:0012115HP:0200084Giant cell hepatitis1TNFSF15 CL E G H9966186ORPHA05011931604052
HP:0012115HP:0200119Acute hepatitis1TNFSF15 CL E G H9966186ORPHA05011931604052
HP:0012115HP:0004787Fulminant hepatitis1TNFSF15 CL E G H9966186ORPHA05011931604052
HP:0012115HP:0006562Viral hepatitis1TNFSF15 CL E G H9966186ORPHA05011931604052
HP:0012115HP:0200123Chronic hepatitis1TNFSF15 CL E G H9966186ORPHA05011931604052
HP:0012115HP:0032220Interface hepatitis1TNFSF15 CL E G H9966186ORPHA05011931604052
HP:0012115HP:0200122Atypical or prolonged hepatitis1TNPO3 CL E G H23534186ORPHA057517103610032
HP:0012115HP:0200084Giant cell hepatitis1TNPO3 CL E G H23534186ORPHA057517103610032
HP:0012115HP:0200119Acute hepatitis1TNPO3 CL E G H23534186ORPHA057517103610032
HP:0012115HP:0006562Viral hepatitis1TNPO3 CL E G H23534186ORPHA057517103610032
HP:0012115HP:0004787Fulminant hepatitis1TNPO3 CL E G H23534186ORPHA057517103610032
HP:0012115HP:0032220Interface hepatitis1TNPO3 CL E G H23534186ORPHA057517103610032
HP:0012115HP:0200123Chronic hepatitis1TNPO3 CL E G H23534186ORPHA057517103610032
HP:0012115HP:0200122Atypical or prolonged hepatitis1TRAF3IP2 CL E G H107581334ORPHA02461343607043
HP:0012115HP:0200084Giant cell hepatitis1TRAF3IP2 CL E G H107581334ORPHA02461343607043
HP:0012115HP:0200119Acute hepatitis1TRAF3IP2 CL E G H107581334ORPHA02461343607043
HP:0012115HP:0004787Fulminant hepatitis1TRAF3IP2 CL E G H107581334ORPHA02461343607043
HP:0012115HP:0006562Viral hepatitis1TRAF3IP2 CL E G H107581334ORPHA02461343607043
HP:0012115HP:0200123Chronic hepatitis1TRAF3IP2 CL E G H107581334ORPHA02461343607043
HP:0012115HP:0032220Interface hepatitis1TRAF3IP2 CL E G H107581334ORPHA02461343607043
HP:0012115HP:0200122Atypical or prolonged hepatitis1TTC7A CL E G H57217436252ORPHA092719750609332
HP:0012115HP:0200084Giant cell hepatitis1TTC7A CL E G H57217436252ORPHA092719750609332
HP:0012115HP:0200119Acute hepatitis1TTC7A CL E G H57217436252ORPHA092719750609332
HP:0012115HP:0006562Viral hepatitis1TTC7A CL E G H57217436252ORPHA092719750609332
HP:0012115HP:0004787Fulminant hepatitis1TTC7A CL E G H57217436252ORPHA092719750609332
HP:0012115HP:0200123Chronic hepatitis1TTC7A CL E G H57217436252ORPHA092719750609332
HP:0012115HP:0032220Interface hepatitis1TTC7A CL E G H57217436252ORPHA092719750609332
HP:0012115HP:0200122Atypical or prolonged hepatitis1XIAP CL E G H331300635Lymphoproliferative syndrome 2, X-linked300635C1845076OMIM0502592300079
HP:0012115HP:0200084Giant cell hepatitis1XIAP CL E G H331300635Lymphoproliferative syndrome 2, X-linked300635C1845076OMIM0502592300079
HP:0012115HP:0200119Acute hepatitis1XIAP CL E G H331300635Lymphoproliferative syndrome 2, X-linked300635C1845076OMIM0502592300079
HP:0012115HP:0004787Fulminant hepatitis1XIAP CL E G H331300635Lymphoproliferative syndrome 2, X-linked300635C1845076OMIM0502592300079
HP:0012115HP:0006562Viral hepatitis1XIAP CL E G H331300635Lymphoproliferative syndrome 2, X-linked300635C1845076OMIM0502592300079
HP:0012115HP:0200123Chronic hepatitis1XIAP CL E G H331300635Lymphoproliferative syndrome 2, X-linked300635C1845076OMIM0502592300079
HP:0012115HP:0032220Interface hepatitis1XIAP CL E G H331300635Lymphoproliferative syndrome 2, X-linked300635C1845076OMIM0502592300079
HP:0012115HP:0006572Subacute progressive viral hepatitis2BLNK CL E G H2976033110ORPHA029614211604515
HP:0012115HP:0200124Chronic hepatitis due to cryptosporidium infection2BLNK CL E G H2976033110ORPHA029614211604515
HP:0012115HP:0001412Enteroviral hepatitis2BLNK CL E G H2976033110ORPHA029614211604515
HP:0012115HP:0200120Chronic active hepatitis2BLNK CL E G H2976033110ORPHA029614211604515
HP:0012115HP:0006572Subacute progressive viral hepatitis2BTK CL E G H69547ORPHA06751133300300
HP:0012115HP:0200124Chronic hepatitis due to cryptosporidium infection2BTK CL E G H69547ORPHA06751133300300
HP:0012115HP:0001412Enteroviral hepatitis2BTK CL E G H69547ORPHA06751133300300
HP:0012115HP:0200120Chronic active hepatitis2BTK CL E G H69547ORPHA06751133300300
HP:0012115HP:0006572Subacute progressive viral hepatitis2CD79A CL E G H97333110ORPHA01501698112205
HP:0012115HP:0200124Chronic hepatitis due to cryptosporidium infection2CD79A CL E G H97333110ORPHA01501698112205
HP:0012115HP:0001412Enteroviral hepatitis2CD79A CL E G H97333110ORPHA01501698112205
HP:0012115HP:0200120Chronic active hepatitis2CD79A CL E G H97333110ORPHA01501698112205
HP:0012115HP:0006572Subacute progressive viral hepatitis2CD79B CL E G H97433110ORPHA01611699147245
HP:0012115HP:0200124Chronic hepatitis due to cryptosporidium infection2CD79B CL E G H97433110ORPHA01611699147245
HP:0012115HP:0001412Enteroviral hepatitis2CD79B CL E G H97433110ORPHA01611699147245
HP:0012115HP:0200120Chronic active hepatitis2CD79B CL E G H97433110ORPHA01611699147245
HP:0012115HP:0006572Subacute progressive viral hepatitis2CLEC7A CL E G H645811334ORPHA05714558606264
HP:0012115HP:0001412Enteroviral hepatitis2CLEC7A CL E G H645811334ORPHA05714558606264
HP:0012115HP:0200124Chronic hepatitis due to cryptosporidium infection2CLEC7A CL E G H645811334ORPHA05714558606264
HP:0012115HP:0200120Chronic active hepatitis2CLEC7A CL E G H645811334ORPHA05714558606264
HP:0012115HP:0006572Subacute progressive viral hepatitis2GPR35 CL E G H2859171Le Marec Bracq Picaud syndromeORPHA01394492602646
HP:0012115HP:0200124Chronic hepatitis due to cryptosporidium infection2GPR35 CL E G H2859171Le Marec Bracq Picaud syndromeORPHA01394492602646
HP:0012115HP:0001412Enteroviral hepatitis2GPR35 CL E G H2859171Le Marec Bracq Picaud syndromeORPHA01394492602646
HP:0012115HP:0200120Chronic active hepatitis2GPR35 CL E G H2859171Le Marec Bracq Picaud syndromeORPHA01394492602646
HP:0012115HP:0006572Subacute progressive viral hepatitis2IGHM CL E G H350733110ORPHA0835541147020
HP:0012115HP:0200124Chronic hepatitis due to cryptosporidium infection2IGHM CL E G H350733110ORPHA0835541147020
HP:0012115HP:0001412Enteroviral hepatitis2IGHM CL E G H350733110ORPHA0835541147020
HP:0012115HP:0200120Chronic active hepatitis2IGHM CL E G H350733110ORPHA0835541147020
HP:0012115HP:0006572Subacute progressive viral hepatitis2IGLL1 CL E G H354333110ORPHA03105870146770
HP:0012115HP:0200124Chronic hepatitis due to cryptosporidium infection2IGLL1 CL E G H354333110ORPHA03105870146770
HP:0012115HP:0001412Enteroviral hepatitis2IGLL1 CL E G H354333110ORPHA03105870146770
HP:0012115HP:0200120Chronic active hepatitis2IGLL1 CL E G H354333110ORPHA03105870146770
HP:0012115HP:0006572Subacute progressive viral hepatitis2IL12A CL E G H3592186ORPHA0345969161560
HP:0012115HP:0200124Chronic hepatitis due to cryptosporidium infection2IL12A CL E G H3592186ORPHA0345969161560
HP:0012115HP:0001412Enteroviral hepatitis2IL12A CL E G H3592186ORPHA0345969161560
HP:0012115HP:0200120Chronic active hepatitis2IL12A CL E G H3592186ORPHA0345969161560
HP:0012115HP:0006572Subacute progressive viral hepatitis2IL12RB1 CL E G H3594186ORPHA04655971601604
HP:0012115HP:0200124Chronic hepatitis due to cryptosporidium infection2IL12RB1 CL E G H3594186ORPHA04655971601604
HP:0012115HP:0001412Enteroviral hepatitis2IL12RB1 CL E G H3594186ORPHA04655971601604
HP:0012115HP:0200120Chronic active hepatitis2IL12RB1 CL E G H3594186ORPHA04655971601604
HP:0012115HP:0006572Subacute progressive viral hepatitis2IL17F CL E G H1127441334ORPHA013216404606496
HP:0012115HP:0200124Chronic hepatitis due to cryptosporidium infection2IL17F CL E G H1127441334ORPHA013216404606496
HP:0012115HP:0001412Enteroviral hepatitis2IL17F CL E G H1127441334ORPHA013216404606496
HP:0012115HP:0200120Chronic active hepatitis2IL17F CL E G H1127441334ORPHA013216404606496
HP:0012115HP:0006572Subacute progressive viral hepatitis2IL17RA CL E G H237651334ORPHA08885985605461
HP:0012115HP:0200124Chronic hepatitis due to cryptosporidium infection2IL17RA CL E G H237651334ORPHA08885985605461
HP:0012115HP:0001412Enteroviral hepatitis2IL17RA CL E G H237651334ORPHA08885985605461
HP:0012115HP:0200120Chronic active hepatitis2IL17RA CL E G H237651334ORPHA08885985605461
HP:0012115HP:0006572Subacute progressive viral hepatitis2IL17RC CL E G H848181334ORPHA058218358610925
HP:0012115HP:0001412Enteroviral hepatitis2IL17RC CL E G H848181334ORPHA058218358610925
HP:0012115HP:0200124Chronic hepatitis due to cryptosporidium infection2IL17RC CL E G H848181334ORPHA058218358610925
HP:0012115HP:0200120Chronic active hepatitis2IL17RC CL E G H848181334ORPHA058218358610925
HP:0012115HP:0006572Subacute progressive viral hepatitis2IRF5 CL E G H3663186ORPHA0656120607218
HP:0012115HP:0200124Chronic hepatitis due to cryptosporidium infection2IRF5 CL E G H3663186ORPHA0656120607218
HP:0012115HP:0001412Enteroviral hepatitis2IRF5 CL E G H3663186ORPHA0656120607218
HP:0012115HP:0200120Chronic active hepatitis2IRF5 CL E G H3663186ORPHA0656120607218
HP:0012115HP:0006572Subacute progressive viral hepatitis2LRRC8A CL E G H5626233110ORPHA032119027608360
HP:0012115HP:0200124Chronic hepatitis due to cryptosporidium infection2LRRC8A CL E G H5626233110ORPHA032119027608360
HP:0012115HP:0001412Enteroviral hepatitis2LRRC8A CL E G H5626233110ORPHA032119027608360
HP:0012115HP:0200120Chronic active hepatitis2LRRC8A CL E G H5626233110ORPHA032119027608360
HP:0012115HP:0006572Subacute progressive viral hepatitis2MMEL1 CL E G H79258186ORPHA018114668618104
HP:0012115HP:0200124Chronic hepatitis due to cryptosporidium infection2MMEL1 CL E G H79258186ORPHA018114668618104
HP:0012115HP:0001412Enteroviral hepatitis2MMEL1 CL E G H79258186ORPHA018114668618104
HP:0012115HP:0200120Chronic active hepatitis2MMEL1 CL E G H79258186ORPHA018114668618104
HP:0012115HP:0006572Subacute progressive viral hepatitis2MST1 CL E G H4485171Le Marec Bracq Picaud syndromeORPHA0577380142408
HP:0012115HP:0200124Chronic hepatitis due to cryptosporidium infection2MST1 CL E G H4485171Le Marec Bracq Picaud syndromeORPHA0577380142408
HP:0012115HP:0001412Enteroviral hepatitis2MST1 CL E G H4485171Le Marec Bracq Picaud syndromeORPHA0577380142408
HP:0012115HP:0200120Chronic active hepatitis2MST1 CL E G H4485171Le Marec Bracq Picaud syndromeORPHA0577380142408
HP:0012115HP:0006572Subacute progressive viral hepatitis2PIEZO1 CL E G H9780194380Xerocytosis194380C0272051OMIM0143328993611184
HP:0012115HP:0200124Chronic hepatitis due to cryptosporidium infection2PIEZO1 CL E G H9780194380Xerocytosis194380C0272051OMIM0143328993611184
HP:0012115HP:0001412Enteroviral hepatitis2PIEZO1 CL E G H9780194380Xerocytosis194380C0272051OMIM0143328993611184
HP:0012115HP:0200120Chronic active hepatitis2PIEZO1 CL E G H9780194380Xerocytosis194380C0272051OMIM0143328993611184
HP:0012115HP:0006572Subacute progressive viral hepatitis2PIK3R1 CL E G H529533110ORPHA04578979171833
HP:0012115HP:0001412Enteroviral hepatitis2PIK3R1 CL E G H529533110ORPHA04578979171833
HP:0012115HP:0200124Chronic hepatitis due to cryptosporidium infection2PIK3R1 CL E G H529533110ORPHA04578979171833
HP:0012115HP:0200120Chronic active hepatitis2PIK3R1 CL E G H529533110ORPHA04578979171833
HP:0012115HP:0006572Subacute progressive viral hepatitis2POU2AF1 CL E G H5450186ORPHA0399211601206
HP:0012115HP:0001412Enteroviral hepatitis2POU2AF1 CL E G H5450186ORPHA0399211601206
HP:0012115HP:0200124Chronic hepatitis due to cryptosporidium infection2POU2AF1 CL E G H5450186ORPHA0399211601206
HP:0012115HP:0200120Chronic active hepatitis2POU2AF1 CL E G H5450186ORPHA0399211601206
HP:0012115HP:0006572Subacute progressive viral hepatitis2SPIB CL E G H6689186ORPHA03411242606802
HP:0012115HP:0200124Chronic hepatitis due to cryptosporidium infection2SPIB CL E G H6689186ORPHA03411242606802
HP:0012115HP:0001412Enteroviral hepatitis2SPIB CL E G H6689186ORPHA03411242606802
HP:0012115HP:0200120Chronic active hepatitis2SPIB CL E G H6689186ORPHA03411242606802
HP:0012115HP:0006572Subacute progressive viral hepatitis2STAT1 CL E G H6772391487ORPHA055711362600555
HP:0012115HP:0200124Chronic hepatitis due to cryptosporidium infection2STAT1 CL E G H6772391487ORPHA055711362600555
HP:0012115HP:0001412Enteroviral hepatitis2STAT1 CL E G H6772391487ORPHA055711362600555
HP:0012115HP:0200120Chronic active hepatitis2STAT1 CL E G H6772391487ORPHA055711362600555
HP:0012115HP:0006572Subacute progressive viral hepatitis2TBX19 CL E G H9095199296ORPHA016511596604614
HP:0012115HP:0200124Chronic hepatitis due to cryptosporidium infection2TBX19 CL E G H9095199296ORPHA016511596604614
HP:0012115HP:0001412Enteroviral hepatitis2TBX19 CL E G H9095199296ORPHA016511596604614
HP:0012115HP:0200120Chronic active hepatitis2TBX19 CL E G H9095199296ORPHA016511596604614
HP:0012115HP:0006572Subacute progressive viral hepatitis2TCF3 CL E G H692933110ORPHA074411633147141
HP:0012115HP:0200124Chronic hepatitis due to cryptosporidium infection2TCF3 CL E G H692933110ORPHA074411633147141
HP:0012115HP:0001412Enteroviral hepatitis2TCF3 CL E G H692933110ORPHA074411633147141
HP:0012115HP:0200120Chronic active hepatitis2TCF3 CL E G H692933110ORPHA074411633147141
HP:0012115HP:0006572Subacute progressive viral hepatitis2TCF4 CL E G H6925171Le Marec Bracq Picaud syndromeORPHA0106911634602272
HP:0012115HP:0200124Chronic hepatitis due to cryptosporidium infection2TCF4 CL E G H6925171Le Marec Bracq Picaud syndromeORPHA0106911634602272
HP:0012115HP:0001412Enteroviral hepatitis2TCF4 CL E G H6925171Le Marec Bracq Picaud syndromeORPHA0106911634602272
HP:0012115HP:0200120Chronic active hepatitis2TCF4 CL E G H6925171Le Marec Bracq Picaud syndromeORPHA0106911634602272
HP:0012115HP:0006572Subacute progressive viral hepatitis2TNFSF15 CL E G H9966186ORPHA05011931604052
HP:0012115HP:0200124Chronic hepatitis due to cryptosporidium infection2TNFSF15 CL E G H9966186ORPHA05011931604052
HP:0012115HP:0001412Enteroviral hepatitis2TNFSF15 CL E G H9966186ORPHA05011931604052
HP:0012115HP:0200120Chronic active hepatitis2TNFSF15 CL E G H9966186ORPHA05011931604052
HP:0012115HP:0006572Subacute progressive viral hepatitis2TNPO3 CL E G H23534186ORPHA057517103610032
HP:0012115HP:0001412Enteroviral hepatitis2TNPO3 CL E G H23534186ORPHA057517103610032
HP:0012115HP:0200124Chronic hepatitis due to cryptosporidium infection2TNPO3 CL E G H23534186ORPHA057517103610032
HP:0012115HP:0200120Chronic active hepatitis2TNPO3 CL E G H23534186ORPHA057517103610032
HP:0012115HP:0006572Subacute progressive viral hepatitis2TRAF3IP2 CL E G H107581334ORPHA02461343607043
HP:0012115HP:0200124Chronic hepatitis due to cryptosporidium infection2TRAF3IP2 CL E G H107581334ORPHA02461343607043
HP:0012115HP:0001412Enteroviral hepatitis2TRAF3IP2 CL E G H107581334ORPHA02461343607043
HP:0012115HP:0200120Chronic active hepatitis2TRAF3IP2 CL E G H107581334ORPHA02461343607043
HP:0012115HP:0006572Subacute progressive viral hepatitis2TTC7A CL E G H57217436252ORPHA092719750609332
HP:0012115HP:0200124Chronic hepatitis due to cryptosporidium infection2TTC7A CL E G H57217436252ORPHA092719750609332
HP:0012115HP:0001412Enteroviral hepatitis2TTC7A CL E G H57217436252ORPHA092719750609332
HP:0012115HP:0200120Chronic active hepatitis2TTC7A CL E G H57217436252ORPHA092719750609332
HP:0012115HP:0006572Subacute progressive viral hepatitis2XIAP CL E G H331300635Lymphoproliferative syndrome 2, X-linked300635C1845076OMIM0502592300079
HP:0012115HP:0200124Chronic hepatitis due to cryptosporidium infection2XIAP CL E G H331300635Lymphoproliferative syndrome 2, X-linked300635C1845076OMIM0502592300079
HP:0012115HP:0001412Enteroviral hepatitis2XIAP CL E G H331300635Lymphoproliferative syndrome 2, X-linked300635C1845076OMIM0502592300079
HP:0012115HP:0200120Chronic active hepatitis2XIAP CL E G H331300635Lymphoproliferative syndrome 2, X-linked300635C1845076OMIM0502592300079


Genes (67) :AIRE ALMS1 AMACR APC ATP7A ATP7B AXIN1 BLNK BTK C1S C4B CASP8 CD40LG CD79A CD79B CIITA CLEC7A CTNNB1 CYP7A1 CYP7B1 GLIS3 GPR35 GUSB HSD3B7 IGF2R IGHM IGLL1 IL12A IL12RB1 IL17F IL17RA IL17RC IL21R IRF5 KRT18 LRRC8A MET MMEL1 MST1 PDGFRL PGM1 PIEZO1 PIK3CA PIK3R1 POU2AF1 RFX5 RFXANK RFXAP SERPINA1 SH2D1A SHPK SKIV2L SLC25A15 SPIB STAT1 TBX19 TCF3 TCF4 TNFSF15 TNPO3 TP53 TPP2 TRAF3IP2 TTC7A VIPAS39 VPS33B XIAP

Diseases (40) :198 33110 47 613783 1334 209902 613812 610199 171 584 186 614921 194380 60 440713 614602 391487 199296 444463 436252 300635 214950 905 277900 308230 209920 607765 308240 238970 243150 613404 208085 240300 203800 114550 300755 307200 614379 615207 118900
 

Human Phenotype Ontology(HPO) is developed by the Human Phenotype Ontology Consortium. The version used here is August 2021 release.